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http://www.biomedcentral.com/1471-2466/12/38RESEARCH ARTICLE Open AccessIntratracheally administered titanium dioxide or
carbon black nanoparticles do not aggravate
elastase-induced pulmonary emphysema in rats
Agnès Roulet1,2†, Lucie Armand1,2†, Maylis Dagouassat1,2, Françoise Rogerieux3, Angélique Simon-Deckers1,2,
Esther Belade1,2, Jeanne Tran Van Nhieu2,4, Sophie Lanone1,2,5, Jean-Claude Pairon1,2,5, Ghislaine Lacroix3
and Jorge Boczkowski1,2,5,6*Abstract
Background: Titanium dioxide (TiO2) and carbon black (CB) nanoparticles (NPs) have biological effects that could
aggravate pulmonary emphysema. The aim of this study was to evaluate whether pulmonary administration of TiO2
or CB NPs in rats could induce and/or aggravate elastase-induced emphysema, and to investigate the underlying
molecular mechanisms.
Methods: On day 1, Sprague-Dawley rats were intratracheally instilled with 25 U kg−1 pancreatic porcine elastase or
saline. On day 7, they received an intratracheal instillation of TiO2 or CB (at 100 and 500 μg) dispersed in bovine
serum albumin or bovine serum albumin alone. Animals were sacrificed at days 8 or 21, and bronchoalveolar
lavage (BAL) cellularity, histological analysis of inflammation and emphysema, and lung mRNA expression of heme
oxygenase-1 (HO-1), interleukin-1β (IL-1β), macrophage inflammatory protein-2, monocyte chemotactic protein-1,
and matrix metalloprotease (MMP)-1, and -12 were measured. In addition, pulmonary MMP-12 expression was also
analyzed at the protein level by immunohistochemistry.
Results: TiO2 NPs per se did not modify the parameters investigated, but CB NPs increased perivascular/
peribronchial infiltration, and macrophage MMP-12 expression, without inducing emphysema. Elastase
administration increased BAL cellularity, histological inflammation, HO-1, IL-1β and macrophage MMP-12 expression
and induced emphysema. Exposure to TiO2 NPs did not modify pulmonary responses to elastase, but exposure to
CB NPs aggravated elastase-induced histological inflammation without aggravating emphysema.
Conclusions: TiO2 and CB NPs did not aggravate elastase-induced emphysema. However, CB NPs induced
histological inflammation and MMP-12 mRNA and protein expression in macrophages.
Keywords: COPD, Occupational medicine, Particles, ToxicityBackground
Pulmonary emphysema is a chronic degenerative lung
disease characterized by an imbalance in alveolar destruc-
tion and repair that results in progressive destruction
of pulmonary alveoli and chronic respiratory failure [1].
Pulmonary emphysema is one of the components of
chronic obstructive pulmonary disease (COPD), a frequent* Correspondence: jorge.boczkowski@inserm.fr
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reproduction in any medium, provided the orcondition with a worldwide prevalence of more than 10%
in men older than 40 years. The prevalence and mortality
of COPD are predicted to further increase in the next
decades [2]. Different processes are involved in alveolar
destruction in emphysema, particularly excess of pro-
tease expression and activity in the lung. In addition to
neutrophil elastase, macrophage matrix metalloprotei-
nase (MMP)-1 and -12 have a critical role in pulmonary
emphysema (see reference [3] for review).
Nanotechnology is a continually developing field.
Reducing a particle’s size to the nanometric dimension
can greatly modify its properties for applications inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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However, concerns have arisen about the possible effects
of these manufactured nanoparticles (NPs) on the health
of users and/or workers manipulating them [4]. Indeed,
the adverse health effects and toxicity of NPs are being
increasingly evaluated (see for example reference [5]).
Titanium dioxide (TiO2) is one of the most abundantly
produced NPs [6]. Because of its optical, photocata-
lytic and self-cleaning properties, it is widely used in
paints, pigments, and cosmetics. Nevertheless, exposure
to TiO2 NPs has various biological effects [7]. Respira-
tory exposure to TiO2 NPs in animals was found asso-
ciated with pulmonary inflammation [8,9], parenchymal
remodeling [10], including emphysema [11], and cancer
[12]. TiO2 NPs exposure has been linked to an increase
in MMP expression: MMP-12 in murine macrophages
[13] and MMP-7, -9 and -10 in keratinocytes [14].
Moreover, TiO2 NPs induced the expression of
interleukin-1β (IL-1β) [9], a strong inducer of MMP-1
[15]. Therefore, we hypothesized that exposure to TiO2
NPs could lead to and/or aggravate pre-existing pulmon-
ary emphysema, given the roles of MMP-1 and MMP-12
in the pathophysiology of the disease [1]. The potential
aggravation of pre-existing emphysema by TiO2 NPs is
important because of the frequency of COPD and the
possibility of patients with COPD having been exposed
to TiO2 NPs.
Carbon black (CB) NPs are also abundantly produced
[6]. Exposure to CB NPs can induce cell apoptosis [16],
inflammation [17], or aggravate already existing patho-
logic conditions such as elastase-induced lung injury
[18]. However, the comparative effects of CB and TiO2
NPs on emphysema induction or aggravation have not
been examined yet. This is an important point because
the effects of NPs depend in part on their chemical
nature, and thus we can expect differences in emphy-
sema generation and/or aggravation related to the chem-
ical nature of the considered NP.
Therefore, we aimed to assess whether pulmonary ad-
ministration of TiO2 or CB NPs in rats could induce
and/or aggravate emphysema and to investigate the
molecular mechanisms involved. We used a well-
established elastase-induced pulmonary emphysema rat
model, which reproduces key phenomena occurring in
alveolar walls of patients with emphysema [19-21]. NPs
were administered 7 days after elastase instillation, to
assess the effects on the development of already consti-
tuted but still progressing emphysema [21]. We exam-
ined animals at 2 time-points and exposed them to 2
doses of TiO2 or CB NPs. We also characterized the
physicochemical properties of NPs in terms of size,
morphologic features, surface area, degree of dispersion
and endotoxin content, as factors able to influence their
biological properties [5,22].Methods
Chemicals
Anatase TiO2 NPs (reference 637264) were purchased
from Sigma Aldrich (St Louis, MO, USA). CB NPs
(reference Carbon Black FW 2) were purchased from
Degussa (Dusseldorf, Germany). In order to disperse
NPs using a biological agent, TiO2 and CB NPs were
suspended in 0.5 mg/ml bovine serum albumin (BSA,
Sigma Aldrich, St Louis, MO, USA) as described previ-
ously [23].
Characterization of NPs
Specific surface area was measured using Brunauer
Emmett Teller (BET) adsorption isotherms of nitrogen
at 77 K. Particle Size Distribution (PSD) function and
zeta potential were determined in saline + 0.5 mg/ml
BSA using a Zetasizer Nano S (Malvern Instruments
Ltd, Worcestershire, UK). Transmission electronic micro-
scopy (TEM) was performed in NPs suspensions filtered
and dried overnight on 200-mesh copper grids. Represen-
tative images of the samples were taken using a JEOL
1200 EXII transmission electron microscope (OXFORD
LINK ISIS 300) and analyzed using an image analyzer
(SAISAM Software, Microvision). NPs endotoxin content
was examined using the Limulus Amebocyte Lysate
(LAL) kit QCL-1000 (Lonza, Basel, Switzerland) accord-
ing to the manufacturer’s instructions.
Animals
240 male Sprague-Dawley rats aged 6 to 8 weeks were
purchased from Janvier (Le Genest Saint Isle, France).
The rats were kept in a conventional animal facility and
housed in positive-pressure air-conditioned units (22 °C,
60% relative humidity) on a 12 h:12 h light/dark cycle.
They had ad libitum access to food and water. The
experimental protocol has been approved by the ethical
committee for animal research of the INERIS (“Institut
National de l’Environnement Industriel et des Risques”,
French National Institute of Industrial Environment
and Risks).
Intratracheal instillation studies
All animals were anaesthetized by intramuscular injec-
tion of a mixture of ketamine (1.6 mg, Merial, Lyon,
France) and xylazine (300 μg, Bayer, Puteaux, France).
The trachea was surgically exposed, and sterile saline
solution or 25 U kg−1 porcine pancreatic elastase (Elastin
Products, Owensville, MO) diluted in sterile saline solu-
tion was instilled, in a volume of 150 μl. Seven days after
elastase or saline instillation (D7), rats underwent intra-
tracheal instillation with BSA (0.5 mg/ml) or TiO2 or CB
NPs (100 or 500 μg/rat). Half of the rats were sacrificed
the day after NPs instillation (day 8 [D8] after elastase),
and the other half 14 days after NPs instillation (day 21




Sequences (5′-> 3′) Product
size (bp)
HO-1 NM_012580.2 TGCTGACAGAGGAACACAAAGA 186
CGGTCGCCAACAGGAAACT
IL-1β NM_031512.2 CTGTGACTCGTGGGATGATG 210
GGGATTTTGTCGTTGCTTGT
MCP-1 NM_031530 CCAGAAACCAGCCAACTCTCA 90
TGTGAACAACAGGCCCAGAAG
MIP-2 NM_053647.1 AGGATCGTCCAAAAGATACTGAACA 90
TTGATTCTGCCCGTTGAGGTA
MMP-1 NM_001134530.1 GCCAACAGGTGCAACAACAC 186
GCATCAAGTTTACCTGGCAGATT
MMP-12 NM_053963.2 CCCCAACACATTTCGTCTCTCT 90
GGATTTGTCAAGGATGGGTTT
HPRT NM_012583.2 TTGGAAAGGGTGTTTATTCCTCAT 261
ATCCAGCAGGTCAGCAAAGAA
Abbreviations: HO-1 heme oxygenase-1, IL-1β interleukin-1β, MCP-1
macrophage inflammatory protein-2, MIP-2 monocyte chemotactic protein-1,
MMP-1 matrix metalloprotease-1, MMP-12 matrix metalloprotease-12, HPRT
hypoxanthine phosphoribosyltransferase.
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(n = 10 in each one) were constituted per sacrifice time
(D8 and D21, respectively) and per dose of NPs (100 μg
and 500 μg, respectively): saline+BSA (S-BSA), saline+
TiO2 (S-TiO2), saline+CB (S-CB), elastase + SA (E-BSA),
elastase +TiO2 (E-TiO2), and elastase+CB (E-CB).
For each experimental condition, 2 groups (group A
and group B) of rats were used, with 6 animals in group
A and 4 in group B. Bronchoalveolar lavage (BAL) and
Real-Time quantitative PCR (RT-qPCR) of the total lung
were performed on rats included in group A. Histopath-
ology and immunohistochemistry were performed in the
lungs of rats included in group B. These lungs were fixed
by airway instillation with 4% phosphate buffered paraf-
ormaldehyde at a pressure of 20 cm fluid column for
24 h, before being embedded in paraffin. Great-axis sa-
gittal sections (5 μm) were performed in a systematic
manner on the same part of the lung. Some sections
were stained with hematoxylin and eosin (H&E) for
histological studies; others were kept unstained for immu-
nohistochemical analysis.
Broncho alveolar lavage cellularity
BAL cellularity was analyzed in anesthetized animals as
previously described [24].
Histopathological analysis
We quantified histological markers of inflammation and
emphysema by optical microscopy (Zeiss Axiophot, Carl
Zeiss, Oberkochen, Germany). The inflammatory abnor-
malities studied were the following: alveolar inflamma-
tion, perivascular oedema and perivascular/peribronchial
infiltration as described previously [25]. Analysis and
quantification of the histopathological alterations were
performed by 2 independent investigators, including an
unrelated expert pathologist who was blinded from the
experimental design and the treatments the animals
received. From every animal, four to five sections were
taken from different depths to give a representative
appreciation of the whole lung. All histological altera-
tions of the same type present on each section were
photographed, and surrounded using the Zeiss Axiovi-
sion 40 software (Carl Zeiss), which gave the corre-
sponding area for each alteration. In each section, a
global alteration score of each inflammatory abnormality
was calculated as the sum of the areas obtained. Median
areas were determined from the different sections of the
individual animals, and area values of the different experi-
mental groups were calculated from the individual values.
Emphysema was quantified as described previously
[24,26]. Briefly, the lungs were fixed with 2.5% glutaral-
dehyde at a transpleural pressure of 25 cmH2O for 3 h
and held in 4% paraformaldehyde (Sigma). Great-axis
sagittal sections (5 μm) of the left lung were cut in asystematic fashion and were stained with hematoxylin
and eosin. Three black-and-white digital photomicro-
graphs were acquired from the cranial, medial, and cau-
dal regions of each slide at X40 magnification, excluding
areas where large bronchi or vessels predominated,
resulting in a total of 9 images per lung. Emphysema
was then quantified by measurement of the mean chord
length of alveoli [27,28] with Analysis software (Soft
Imaging System, Münster, Germany) at a 5-μm interval.
The analysis was performed in duplicate by two blinded
observers (AR and LA). The mean chord length of
alveoli was obtained by averaging those measurements.
RT-qPCR
RT-qPCR in lung homogenates was performed to exam-
ine the mRNA expression of anti-oxidant, inflammatory
and proteases genes as previously described [24]. Genes
analyzed were heme oxygenase 1 (HO-1), interleukin 1β
(IL-1β), macrophage inflammatory protein 2 (MIP-2),
monocyte chemotactic protein 1 (MCP-1), MMP-1 and
MMP-12. The primer sequences are given in Table 1. Gene
expression was normalized to that of hypoxanthine phos-
phoribosyltransferase (HPRT) as a housekeeping gene.
Immnunohistochemistry
Immunohistochemical staining was performed to detect
the protein expression of MMP-12 (anti-MMP-12 anti-
body, Santa Cruz Biotechnology, Santa Cruz, CA; 1:100
dilution) and the macrophage marker CD68 (anti-CD68
antibody, Abcam, Cambridge, UK; dilution 1:200).
Quantification was performed using ImageJ software
[29]. Results were expressed as the percentage of stained
cells versus total cells.
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Data were expressed as median and interquartile range
(IQR; 25th and 75th percentiles). Analysis was performed
using GraphPad Prism 4.0 software (La Jolla, CA, USA).
Comparisons between multiple groups were performed
using Kruskall-Wallis non-parametric ANOVA followed
by Mann-Whitney U test when a difference was
detected. All comparisons were realized with correction




The detailed physicochemical characterization of NPs
(surface area, primary particle size, zeta potential and
hydrodynamic diameter) is given in Table 2. CB NPs had
a higher specific surface area than TiO2 NPs (p< 0.05).
The primary diameter of CB and TiO2 NPs was not sta-
tistically different. The zeta potential for CB and TiO2
NPs, used to indicate suspension stability, was about
|20| mV, a commonly used limit above which the suspen-
sion is aggregated [30]. Indeed, PSD studies showed
aggregation for both NPs, with a higher average hydro-
dynamic diameter of CB as compared to TiO2 NPs. How-
ever, as for the primary diameter, this difference was not
statistically significant.
No endotoxin was detected whatever NP (data not
shown).
BAL cellularity
At D8 and D21, with saline treatment, NPs instillation
(at both 100 and 500 μg/rat) did not modify BAL cellu-
larity (Figure 1). By contrast, in presence or absence of
NPs, elastase induced a significant increase in total BAL
cellularity as compared to saline treatment (p< 0.05,
Figure 1). Alveolar macrophages represented more than
80% of total cells in BAL, with no significant difference
between groups (Figure 2).
Emphysema quantification
Emphysema was quantified at D21 as described previ-
ously [24,26]. NPs did not induce emphysema per se
(Figure 3). As expected, mean airspace chord length was
greater with elastase than saline treatment (p< 0.05,Table 2 Nanoparticles characterization
Nanoparticle Crystal phase Surface area
(m²/g)
CB Amorphous 373 ± 18 *
TiO2 Anatase 141 ± 6
*: p< 0.05 vs TiO2.
(a)From reference [43].
Abbreviations: CB carbon black, TiO2 titanium dioxide.
Data are mean ± standard error of mean.Figure 3A, B), in absence or presence of whatever dose
of NPs.
Considering that the effects of NPs on BAL cellularity
and emphysema were similar when the animals were
exposed to 100 or 500 μg NPs, we used 500 μg NPs for
the remaining studies.
Histological analysis of inflammation
At D8 and D21, rats receiving saline or elastase showed
no alveolar inflammation nor perivascular oedema in
absence or presence of NPs (Figure 4A-4D).
At D8, with saline treatment, perivascular infiltration
was greater in rats exposed to CB but not TiO2 NPs
than BSA-treated animals (p< 0.05, Figure 4E). Elastase
treatment resulted in a significant increase in perivascu-
lar infiltration (p< 0.05, Figure 4E). Moreover, exposure
of elastase-treated rats to CB slightly but significantly
increased this phenomenon. The infiltrates were mainly
composed of lymphocytes, with also neutrophils and
macrophages (Figure 4G). Some infiltrates were also
located peribronchially. A similar pattern was observed
at D21 (Figure 4F).
Gene expression quantification
At D8, no induction of HO-1, IL-1β, MIP-2, MCP-1,
MMP-1 or MMP-12 was observed after NP exposure
alone, elastase instillation alone or elastase followed by
NP exposure (data not shown).
At D21, with saline treatment, the mRNA levels of
HO-1 and MMP-12 were increased in rats exposed to
CB but not TiO2 NPs (p< 0.05; Figure 5A, F). With
elastase treatment, the mRNA levels of HO-1, IL-1β and
MMP-12 were higher than that with saline treatment
(Figure 5A, B and F); a similar pattern was observed in
rats instilled with CB NPs. With elastase treatment, the
mRNA level of MMP-12 was higher in rats with TiO2
exposure than BSA exposure (Figure 5F).
MMP-12 and CD68 immunohistochemical analysis
To verify whether the increase in MMP-12 mRNA level
was also observed at the protein level, we analyzed the
protein expression of MMP-12 at D21 by immunohisto-
chemical staining. With saline treatment, staining for
MMP-12 protein was greater with CB NPs than BSA






23 ± 6 −21.4 613 ± 145
12 ± 2 −16.9 451 ± 80
Figure 1 Total cell number in BAL. Quantification of BAL total cell number at D8 (A, C) and D21 (B, D) post elastase treatment, in presence of
100 μg (A, B) or 500 μg NPs (C, D). S, saline; E, elastase; BSA, bovine serum albumin. CB, carbon black. TiO2, titanium dioxide. *: p< 0.05 vs S-BSA.
n = 6. Box plots show median and interquartile range (25th and 75th percentiles).
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less of NP exposure.
Because MMP-12-positive cells showed morphologic
features of macrophages, we verified this by performing
CD68 immunostaining in a serial slide compared to theFigure 2 Proportion of alveolar macrophages in BAL. Quantification of
elastase treatment, in presence of 100 μg (A, B) or 500 μg (C, D) NPs. n = 6
and interquartile range (25th and 75th percentiles).one in which MMP-12 was detected. Figure 6C shows
results for CD68 staining similar to that for MMP-12
staining. Besides, most cells expressing MMP-12 also
expressed CD68, which strongly suggests that cells
expressing MMP-12 were macrophages. Stained cellsthe differential cell count in BAL at D8 (A, C) and D21 (B, D) post
. Abbreviations are the same as in Figure 1. Box plots show median
Figure 3 Emphysema quantification. Emphysema quantification assessed by measurement of the alveolar mean chord length at D21, in
presence of 100 μg (A) or 500 μg (B) NPs. *: p< 0.05 vs S-BSA. n = 4. Abbreviations are the same as in Figure 1. Box plots show median and
interquartile range (25th and 75th percentiles).
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vascular and peribronchial infiltrates (Figure 6A). Add-
itionally, NPs aggregates were observed in some CD68
positive cells.
Discussion
The main results of our study are that: 1) TiO2 NPs did
not induce inflammation per se and did not aggravate
elastase-induced pulmonary inflammation and emphy-
sema, except for an increase in elastase-induced MMP-
12 mRNA expression in the lung, and 2) CB NPs
induced perivascular/peribronchial infiltration, increased
HO-1 mRNA expression in the lung and increased
MMP-12 mRNA and protein expression in alveolar
macrophages without inducing emphysema. CB NPs
aggravated elastase-induced perivascular/peribronchial
inflammation but not emphysema. These results demon-
strate that TiO2 or CB NPs did not induce and did not
aggravate elastase-induced emphysema. However, CB
NPs induced a lung inflammatory and protease response
close to that induced by elastase and, notably, macro-
phage MMP-12 expression.
Methodological considerations
We decided to focus this study on the evaluation of NPs
at doses that were relevant in terms of human exposure.
We reasoned in terms of the current time-weighted
average concentrations (TWA) recommendations for
workers exposed to TiO2 (http://www.cdc.gov/niosh/
review/public/tio2/pdfs/TIO2Draft.pdf). These values
are between 1.5 and 15 mg/m3 for a single shift of work
(Table 1 of the above referenced document). In the
present study, we used 0.4 and 2 mg/kg of TiO2 NPs,
corresponding to a total administered-mass of 100 and
500 μg per rat, for a 250 g rat. For a 70 kg human, this
concentration would lead to the total administration of
28 and 140 mg. For a worker inhaling 10 m3 per work-
day, it implies TiO2 concentrations exposure of 2.8 and14 mg/m3, which are in the 2 extremes of the range of
TWA values. Of course, we are aware that only a frac-
tion of this inhaled dust reaches and remains in the
lung. However, it is known that TiO2 particles have a
long retention half-time (between 170 and 500 days for
the fine and ultra-fine TiO2 particles respectively [31]).
Therefore, the calculation of the total administered
dose must take into account the duration between the
day of NP administration and the day the animals are
sacrificed. In our study, we observed a 14 days period
between administration and sacrifice. Therefore, the
dose initially administrated should be divided by 14,
which leads to values well below TWA values.
A potential criticism of this study is the respiratory de-
livery of NPs by a single intratracheal instillation instead
of aerosol exposure. We acknowledge that aerosol
exposure better reflects human exposure than intratra-
cheal instillation. However, intratracheal instillation is
a validated method of respiratory NPs delivery (see for
example [32,33]). Moreover, given the long retention half
time of NPs [31], a single instillation is well adapted to
reproduce continuous exposure during short-term expe-
rimental periods like in the present study. It has to be
noted that we used BSA to disperse the NPs in solution
and this procedure could influence the biological effects
of the NPs, as demonstrated by Val and colleagues
in bronchial epithelial cells exposed to CB and TiO2
NPs [17]. However, other investigators did not find
such interference with investigation of different types
of carbon nanotubes [23]. This aspect should deserve
further investigation.
Another potential criticism of this study is the
utilization of the elastase-induced pulmonary emphy-
sema model to analyze emphysema induced by cigarette
smoke exposure, as occurs in humans. We decided not
to use the cigarette smoke model because cigarette smoke
contains NPs [34] that could prevent from examining the
only effect of CB and TiO2 NPs on emphysema. We think
Figure 4 Quantitative analysis of histological inflammation in animals receiving 500 μg NPs. Histological inflammation was quantified
in terms of alveolar inflammation (A, B), perivascular oedema (C, D) and perivascular/peribronchial infiltration (E, F) 8 days (A, C, E) or 21 days
(B, D, F) after initial elastase administration in animals receiving 500 μg NPs. Data are expressed as the total surface of the histological slide
presenting the histological feature. *: p< 0.05 vs S-BSA. }: p< 0.05 vs E-BSA. n = 4. Abbreviations are the same as in Figure 1. Box plots show
median and interquartile range (25th and 75th percentiles). Panel G: representative histological staining of perivascular/peribronchial infiltrates in
rat lung at D21 in animals exposed to 500 μg NPs. Arrows point to perivascular infiltrates. Magnification x20.
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Figure 5 Gene expression at D21 in animals receiving 500 μg NPs. Quantification of mRNA expression of the different genes at D21 by
RT-qPCR. Data are expressed as the ratio to HPRT as housekeeping gene. Rats were exposed to 500 μg NPs. *: p< 0.05 vs S-BSA. }: p< 0.05
vs E-BSA. n = 6. Abbreviations are the same as in Table 1. Box plots show median and interquartile range (25th and 75th percentiles).
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study for the following reasons. First, animals receiving a
bolus of exogenous elastase into the lung exhibit lung
damage consistent with emphysema, which is progressive
[21], and involves many of the main pathophysiologic
changes observed in cigarette smoke-induced emphysema
in humans and animals, i.e. inflammation, oxidative stress
[35], alveolar cell apoptosis [20] [21], and MMP-12 induc-
tion [21]. Second, elastase-induced emphysema can be
modulated by different conditions (i.e. IL-6 or Nrf2
knocking down [21,35]), showing that it’s a dynamic
process, susceptible to be modulated by exposure to NPs,
which does not result only from initial tissue destructionby exogenous elastase. Moreover, we took care of using a
dose of elastase inducing a degree of emphysema similar
to that observed after cigarette smoke exposure (near 30%
increase in mean linear intercept [36]). Finally, the expres-
sion of major actors of cigarette smoke-induced emphy-
sema, such as HO-1, MMP-12 and IL-1β was increased
in our elastase-instilled animals, supporting the relevance
of the model.
Emphysema was quantified by the measurement of the
mean chord length, which is a standard stereological
method to quantify alveolar surface area [27,28,37,38].
However, care must be taken when using this method
because it can be fraught with a number of pitfalls
Figure 6 Quantification of MMP-12 and CD68 immunostaining at D21 in animals receiving 500 μg NPs. Localization and quantification of
MMP-12 and CD68 on lung sections of rats exposed to 500 μg NPs evaluated at D21 after elastase administration. (A) Representative histological
images of staining for MMP-12 (magnification x20, left column) and CD68 (magnification x20, middle column, magnification x40, right column).
Arrows point to macrophages containing NPs. (B) Quantification of MMP-12-positive cells reported to the total number of cells. (C) Quantification
of CD68-positive cells reported to the total number of cells. *: p< 0.05 vs S-BSA. n = 4. Abbreviations are the same as in Figure 1. Box plots show
median and interquartile range (25th and 75th percentiles).
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slides are primarily determined by the inflation level at
which the specimen has been held during tissue pre-
paration. Therefore, in order to ensure the accuratecomparison of the different groups, particular attention
was paid to fix the lungs at a similar transpleural pres-
sure (25 cmH2O for 3 h) before holding them in 4% par-
aformaldehyde. Second, we ensured that sampling of
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tion of very long intercepts as they occur, when the test
line lies in the direction of alveolar ducts. Finally, care
was taken to avoid any particle contained in the air
space image (a speck of dust for example) that may
intersect the scan line and thus cut an intercept in half
so that two short chords are recorded instead of one
longer one. This point is particularly important in ani-
mals exposed to NPs, since one can consider that iso-
lated NPs in alveolar lumen could behave like a speck of
dust, leading thus to underestimation of emphysema in
these animals. However, no isolated NPs were observed,
and thus this possibility can be ruled out.
Results discussion
We compared NPs that had similar sizes, but different
specific surface areas, since specific surface area was 3
times greater for CB than for TiO2 NPs. In vivo and
in vitro studies demonstrated that the surface area of
NPs could be a main determinant of their pro-
inflammatory effects [16,39-42]. This parameter and/or a
different surface reactivity, related to the chemical na-
ture of the NPs, could explain the difference in their in-
flammatory effects in the present study. It has been
demonstrated that TiO2 and CB NPs elicited distinct
apoptotic pathways [43], which could also impact their
effects on the animals. However, no morphological sign
of apoptosis was observed in the rat lungs. In contrast to
TiO2 NPs, CB NPs induced inflammation and expres-
sion of the oxidative stress marker HO-1 and the prote-
ase MMP-12. Using the same NPs as we used, Hussain
and coworkers [44] showed that the reactivity of CB NPs
was higher than that of TiO2 NPs, as evaluated by the
production of reactive oxygen species in acellular condi-
tions. The increase in HO-1 expression that we observed
supports an oxidative effect of CB NPs [45,46], which
has been already described in bronchial epithelial cells
[43], and could be responsible for the inflammatory ef-
fect of CB NPs [47]. Although we did not find an in-
crease in inflammatory cells in BAL, we observed clear
inflammatory histological alterations (perivascular and
peribronchial infiltration of neutrophils, lymphocytes
and macrophages), as observed previously with other par-
ticles [44,48]. Macrophages engulfed CB NPs, apparent as
pigmentation in the histological sections. In addition to
attracting macrophages to the lung, CB NPs activated
these cells, as revealed by their increased MMP-12 pro-
tein expression detected by immunohistochemistry. We
and others [48,49] showed that different particles, such
Paris Metro or atmospheric particulate matter (PM 10),
could induce MMP-12 expression in macrophages. The
present results provide the first demonstration of an
increase in MMP-12 expression by manufactured NPs,
both at the mRNA and protein levels.Although we analyzed MMP-12 protein expression
and its localization, we did not measure its activity.
However, our results showing MMP-12 protein expres-
sion in macrophages are compatible with the presence
of an active enzyme. Indeed, Cobos-Correa and cowor-
kers [49] demonstrated in mice intratracheally instilled
with PM 10 particles that active MMP-12 is bound to
the membrane of alveolar macrophages. The increase in
MMP-12 expression after a single exposure CB NPs
could have important pathophysiological consequences
because this protease plays a critical role in emphysema
and COPD [50,51]. Continuous exposure to relevant
doses of CB NPs could be consistent with a continuous
degradation of pulmonary elastin, which could lead to a
progressive and chronic degradation of lung function, as
observed in smokers developing COPD [51]. Oxidative
stress, revealed by the increased HO-1 expression,
could explain MMP-12 induction after CB NPs adminis-
tration [52].
TiO2 NPs did not induce inflammation or protease
expression per se but, rather, potentiated MMP-12
mRNA induction by elastase. This result is in line with
data from Hussain and coworkers [44] showing that
TiO2 NPs, at a dose similar to ours, potentiated toluene
diisocyanate-induced allergic inflammation in mice with-
out inducing inflammation per se. However, the rele-
vance of the potentiation of elastase-induced MMP-12
mRNA expression by TiO2 is questionable, because
we were unable to detect a parallel increase in protein
expression. Moreover, this phenomenon was observed in
the absence of a parallel increase in HO-1 and IL-1β
expression, which suggests that the effect of TiO2 NPs
on MMP-12 expression is independent of oxidative stress
or IL-1β induction. Further experiments are needed to
better understand this phenomenon.
CB NPs were unable to potentiate elastase-induced
emphysema, although they induced inflammation and
MMP-12 expression per se and potentiated elastase-
induced perivascular/peribronchial infiltration. This
result agrees with data reported by Inoue and coworkers
[18] in the elastase-induced emphysema model showing
that CB NPs with a specific surface area and a diameter
similar to our NPs, and at a dose similar to that used in
our study, also induced inflammation per se and poten-
tiated elastase-induced inflammation but not emphy-
sema. Inoue and coworkers [18] administered CB NPs
simulatenously with elastase whereas we administered
NPs 1 week after elastase to assess their effects on the
development of already constituted but still progressing
emphysema [21]. The similar absence of potentiation of
emphysema in the 2 studies shows that the timing of CB
NPs administration is not a major determinant of this
phenomenon. One car argue that the relatively short
period elapsed after CB NPs could be insufficient to
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exclude this hypothesis, other interventions such as
administration of macrophage-colony stimulating factor,
in a similar time frame than in the present study,
was able to aggravate elastase-induced emphysema [53].
Interestingly, the potentiation of elastase-induced inflam-
mation by CB NPs is in contrast with a reduced inflam-
matory response to bacterial infection in elastase-instilled
animals [54,55], suggesting a specific effect of NPs in
this model.
Conclusion
This study demonstrates an absence of induction and
aggravation of elastase-induced emphysema with the
administration of relevant doses of TiO2 or CB NPs.
This result shows that not all the exposures to different
NPs are associated with adverse health effects. However,
CB NPs per se aggravated elastase-induced histological
inflammation and increased expression of MMP-12, a
major protease involved in elastin breakdown. Further
studies will be needed to examine the implications of
these findings.
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